Similarly, although glomerulosclerosis and interstitial fibrosis were not different in ARB and TRX groups, a more detailed analysis showed the superior maintenance of WT-1 positive cells, a marker of differentiated podocytes, with ARB treatment. This evidence concerns the gene WT1 and glomerulosclerosis.